AGC
TLSIW icon

Angelo Gordon & Co’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Angelo Gordon & Co’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-69,514
Closed -$384K – 66
2024
Q2 		$384K Sell
69,514
-26,294
-27% -$35.7K 0.15% 37
2024
Q1 		$934K Hold
95,808
– – 0.31% 29
2023
Q4 		$810K Hold
95,808
– – 0.26% 37
2023
Q3 		$491K Hold
95,808
– – 0.19% 42
2023
Q2 		$1M Hold
95,808
– – 0.27% 36
2023
Q1 		$977K Buy
+95,808
New +$8.45K 0.24% 46

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $770M AUM 23.14% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Angelo Gordon & Co's TLSIW Position: Q1 2023 in Review

Angelo Gordon & Co sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2023, closing a stake of 95,808 shares — an estimated $8.45K sold.

Angelo Gordon & Co first reported a position in TLSIW in Q1 2021 and held it in 8 quarters. The position peaked at $961K in Q4 2022. 24 funds tracked by Wall St. Rank hold TLSIW as of Q1 2023.

  • Angelo Gordon & Co reported no remaining TriSalus Life Sciences Warrant position as of Q1 2023 after selling out during the quarter.
  • Angelo Gordon & Co sold 95,808 TriSalus Life Sciences Warrant shares in Q1 2023, an estimated $8.45K.
  • Angelo Gordon & Co first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 8 quarters.
  • Angelo Gordon & Co's TriSalus Life Sciences Warrant position peaked at $961K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2023.

Based on Angelo Gordon & Co's 13F filing for Q1 2023, filed 15 May 2023.